For the Inventor, By the Inventor

Enter assignee name

Palo Alto, CA, United States of America

Celator Pharmaceuticals, Inc.

USPTO Granted Patents = 25

CIPO Patents = 7

EPO Patents = 11

Trademarks = 5

Forward Citations = 572

Loading Chart...

Loading Chart...

36 inventors (with patents filed for the assignee):

Lawrence D Mayer (17 out of 31 patents)

Paul Tardi (15 out of 16 patents)

Murray Webb (7 out of 7 patents)

4. Troy Harasym (6 out of 6 patents)

5. Andrew S Janoff (6 out of 80 patents)

6. Marcel B Bally (6 out of 48 patents)

7. Sharon Johnstone (5 out of 5 patents)

8. Clifford Shew (4 out of 4 patents)

9. Yi Zeng (3 out of 3 patents)

10. David K Watkins (3 out of 16 patents)

11. Donna J Cabral-Lilly (3 out of 9 patents)

12. Daryl C Drummond (2 out of 36 patents)

13. Leon Wan (2 out of 2 patents)

14. Winnie Lui (2 out of 2 patents)

15. Bolin Geng (2 out of 10 patents)

25 patents: Sort by Forward Citations

1. 12370207 - Low-intensity treatment of hematological disorders (2025-07-29),

2. 12070471 - Remote loading of sparingly water-soluble drugs into lipid vesicles (2024-08-27),

3. 11787781 - Inhibiting ataxia telangiectasia and RAD3-related protein (ATR) (2023-10-17),

4. 11746386 - Assays and methods for selecting a treatment regimen for a subject with leukemia (2023-09-05),

5. 11583544 - Remote loading of sparingly water-soluble drugs into lipid vesicles (2023-02-21),

6. 11413253 - Nanoparticle delivery systems (2022-08-16),

7. 11028076 - Inhibiting ataxia telangiectasia and Rad3-related protein (ATR) (2021-06-08),

8. 10927418 - Assays and methods for selecting a treatment regimen for a subject with leukemia (2021-02-23),

9. 10905775 - Particulate constructs for release of active agents (2021-02-02),

10. 10835492 - Method of lyophilizing liposomes (2020-11-17),

11. 10722464 - Compositions for delivery of drug combinations (2020-07-28),

12. 10285951 - Nanoparticle delivery systems (2019-05-14),

13. 10166184 - Method of lyophilizing liposomes (2019-01-01),

14. 10058507 - Compositions for delivery of drug combinations (2018-08-28),

15. 10028912 - Method of lyophilizing liposomes (2018-07-24),

Celator Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing novel therapies for the treatment of cancer. Their mission is to improve patient outcomes by delivering next-generation targeted chemotherapy regimens. With a focus on combination chemotherapy, Celator aims to enhance therapeutic efficacy and minimize toxicity. The company employs innovative drug delivery platforms to develop proprietary drug combinations with the potential to address unmet medical needs in various types of cancer.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

25 Patents

#81 in Palo Alto, CA

#3,062 in California

#12,936 in US

#24,954 in the World

Palo Alto, CA, United States of America

Celator Pharmaceuticals, Inc.

Forward Citations = 572

36 inventors:

Lawrence D Mayer (17 out of 31 patents)

Paul Tardi (15 out of 16 patents)

Murray Webb (7 out of 7 patents)

4. Troy Harasym (6 out of 6 patents)

5. Andrew S Janoff (6 out of 80 patents)

Please report any incorrect information to support@idiyas.com

Loading…